Contact Us

Ilae Facebook Ilae Twitter


3rd African Epilepsy Congress

2017 AEC Dakar

More than 280 participants from 48 different countries met in Dakar, Senegal for the third African Epilepsy Congress, centered on the theme, "Child and Adolescent Epilepsy."
View full report and photo gallery.

2017-2021 Regional Commission Elections Results

Elections for Regional Commission Chairs and members are now complete. View full commissions:

 Angelina Kakooza
Angelina Kakooza

Akio Ikeda
Akio Ikeda
Asia and Oceania

Chahnez Charfi Triki
Chahnez Charfi Triki
Eastern Meditranean

Eugen Trinka
Eugen Trinka

Roberto Caraballo
Roberto Caraballo
Latin America

Nathalie Jette
Nathalie Jetté
North America

News from ILAE All news

From the Chilean chapter

Chilean League Against Epilepsy

Con profundo pesar, comunicamos el sensible fallecimiento de nuestro destacado socio, Fundador de la Sociedad de Epileptologia de Chile. Capitulo Chileno de ILAE. Expresidente de la Sociedad de Epileptología y hasta la fecha miembro de nuestro Directorio, Dr. Marcelo Devilat Barros.


Epilepsia and Epileptic Disorders announce increased Impact Factors



The ILAE and the editors of Epilepsia are pleased to announce that the impact factor of Epilepsia has increased from 4.706 to 5.295.
View the 10 most-cited papers here.


Epileptic Disorders

The ILAE and the editors of Epileptic Disorders are pleased to announce that the impact factor of Epileptic Disorders has increased from 0.9426 to 1.168.
View the 10 most-consulted articles here.

Caret imageMore news from ILAE

News Around the World All news

Study could help explain link between seizures and psychiatric disorders

Cells related to seizures, schizophrenia, and ADHD all found in the same region of the brain. More …

Retigabine to be discontinued in June

We have received a reminder notice from GSK that retigabine (Trobalt®/Potiga®) will be removed from clinical use at the end of June. Please discuss the issues with any patient who remains on the medication and how they need to be transitioned to other drugs as clinically indicated. Details here.

Caret imageMore news around the world

Clinical Research News All news

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Among patients with the Dravet syndrome, cannabidiol resulted in a greater reduction in convulsive-seizure frequency than placebo and was associated with higher rates of adverse events. (NEJM, May 25, 2017) More …

Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.

The paper proposes a web-based tool to calculate the risk of seizure relapse after withdrawal of antiepileptic medication. (Lancet Neurology, 2017 May 5). More …

Caret imageMore clinical research news

Basic Science of Epilepsy News All news

Optogenetic Low-Frequency Stimulation of Specific Neuronal Populations Abates Ictogenesis

This study was done to investigate whether LFS with optogenetic stimulation of calcium/calmodulin-dependent protein kinase II-positive (CaMKII-positive) principal cells, and parvalbumin or somatostatin-positive interneurons was able to reduce epileptiform activity caused by 4-AP in the entorhinal cortex (EC). (Journal of Neuroscience 15 March 2017) More | Summary for non specialists

Caret imageMore basic science news

VIREPA Applications now open

Application for the 2017-2018 academic year is now open. Applications will be accepted until August 4, 2017

Caret image See VIREPA courses and apply


ILAE eNewsletter

To subscribe, please provide your email address:

Caret imageRead June issue


Epilepsy & Sports

Guilherme Prata Ribeiro
Portuguese rugby star Guilherme Prata Ribeiro with Afonso Ramos
Stand Up For Epilepsy® and for full participation in sports.

Caret imageBook, photos, and information about the
Epilepsy & Sport Project



Home | Contact Us | Privacy & Security | Login | Sitemap
Creative Commons License
Text on this website is available under a
Creative Commons Attribution-ShareAlike 4.0 International License
except all videos and images, which remain copyrighted by the International League Against Epilepsy.